Molecular Profiling Guides Adjuvant Endometrial Cancer Treatment with Reduced Early Toxicity
Results from the phase 3 PORTEC-4a trial show that tailoring adjuvant therapy by molecular risk profile significantly curtails early toxicities ...
Results from the phase 3 PORTEC-4a trial show that tailoring adjuvant therapy by molecular risk profile significantly curtails early toxicities ...
A systematic review and meta-analysis found that low-frequency repetitive transcranial magnetic stimulation significantly reduced seizure frequency and interictal epileptiform discharges ...
A retrospective cohort study of 100 hospitalized patients found that adding recombinant human brain natriuretic peptide to levosimendan was associated ...
A retrospective study of four children reveals divergent outcomes and dosing challenges in mustard oral immunotherapy without establishing efficacy.
A real-world multicenter study in Türkiye reports that larotrectinib achieved high response rates in pediatric extracranial NTRK fusion-positive tumors, particularly ...
A retrospective cohort study found swallowable and endoscopically inserted gastric balloons produced similar weight loss, though swallowable devices were associated ...
A meta-analysis of randomized controlled trials reveals mesenchymal stem cell treatment significantly lowers mortality and serious adverse events in viral ...
A retrospective cohort study found no statistically significant difference in two-month treatment outcomes between low-dose and moderate-dose prednisolone in patients ...
A prospective Canadian observational study found that two-thirds of adults with moderate-to-severe atopic dermatitis achieved clear or almost clear skin ...
A systematic review of six randomized controlled trials found no significant difference in pain or functional outcomes between epidural platelet-rich ...
A retrospective study of FDA adverse event reports from 2012 to 2024 finds that PET radiopharmaceuticals maintain a low risk ...
A semi-parametric adaptation of the prevalence function accounts for patient confounding factors when evaluating the evolution of adverse events in ...
A retrospective study of 111 patients found that early clinical response to broadband light therapy strongly correlated with overall success ...
A retrospective study of 40 patients found that bleomycin-lauromacrogol foam achieved an 85 percent excellent response rate for lymphatic malformations ...
A single-arm exploratory study reports an 88.2 percent 12-week objective response rate and preliminary two-year survival estimates for nimotuzumab added ...
A prospective study in BMC Emergency Medicine found that adverse events occurred in 24.2% of intrahospital transports for critically ill ...
A scoping review and Brazilian regulatory data analysis show that real-world data are becoming strategic components of lifecycle-based post-market surveillance ...
A systematic review and meta-analysis of three randomized controlled trials found that linerixibat modestly reduces pruritus severity and sleep interference ...
A longitudinal study shows that hematologic reductions from lutetium-177 dotatate therapy in gastroenteropancreatic neuroendocrine tumor patients largely rebound into normal ...
A systematic review and meta-analysis of eight randomized controlled trials demonstrates that adding pertuzumab to standard therapies significantly improves progression-free ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.